Next Article in Journal
Paternal Preconception Every-Other-Day Ethanol Drinking Alters Behavior and Ethanol Consumption in Offspring
Previous Article in Journal
Effect of Hand and Foot Massage Therapy on Psychological Factors and EEG Activity in Elderly People Requiring Long-Term Care: A Randomized Cross-Over Study
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessCase Report

Stromal Vascular Fraction Cell Therapy for a Stroke Patient—Cure without Side Effects

1
Internal Consortium for Cell Therapy and Immunotherapy, Videnska 119, 619 00 Brno, Czech Republic
2
Cellthera Clinic, Videnska 119, 619 00 Brno, Czech Republic
3
Ordination DDr. Heinrich, Landhausgasse 2, 1010 Wien, Austria
*
Author to whom correspondence should be addressed.
Brain Sci. 2019, 9(3), 55; https://doi.org/10.3390/brainsci9030055
Received: 23 January 2019 / Revised: 1 March 2019 / Accepted: 4 March 2019 / Published: 6 March 2019
(This article belongs to the Special Issue Adult Neurogenesis and Neurological Disorders)
  |  
PDF [598 KB, uploaded 6 March 2019]
  |     |  

Abstract

A 48-year-old male, who suffered from a stroke resulting in cerebellum damage and occlusion of the left vertebral artery, underwent stromal vascular fraction therapy. The clinical status of the patient was monitored by a modified Stroke Specific Quality of Life Scale before therapy and at 3, 9, 12, 18, 24, and 32 months after therapy. Three months after therapy, the patient felt a reduction in pain, vertigo, and fatigue. After 9 months, he was able to walk safely on his own. After 24 months, he was able to ride a bicycle. After 32 months, he felt completely healthy without any limitations or handicaps. Therefore, intravenous application of stromal vascular fraction cells represents a promising strategy for the treatment of patients after a stroke. View Full-Text
Keywords: stromal vascular fraction; cell therapy; stroke stromal vascular fraction; cell therapy; stroke
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Michalek, J.; Vrablikova, A.; Heinrich, K.G.; Dudasova, Z. Stromal Vascular Fraction Cell Therapy for a Stroke Patient—Cure without Side Effects. Brain Sci. 2019, 9, 55.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Brain Sci. EISSN 2076-3425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top